-
Letter From the Editors
A Singleness of Purpose— A Spectrum of Expertise and Care— What Will the Future Bring?
J. Lyle Bootman, PhD Co-Editor
Daniel D. Von Hoff, MD Co-Editor
-
Publisher’s Statement
Raising Cain
James M. La Rossa Jr.
-
Pharmacy Practice
New Medicines in Development for Cancer
Pharmaceutical Research and Manufacturers of America (PhRMA)
-
Pharmacoeconomics of Cisplatin-Based Chemoradiation in Cervical Cancer: A Review
Peter G. Rose, MD, and Panos T. Lappas
-
Increased Mortality Risk Associated With Medial Breast Tumors May Be Due to Untreated Internal Mammary Node Metastases
Caroline Lohrisch, MD
-
Colorectal Cancer Screening: How Are We Doing and How Can We Improve?
Virender K. Sharma, MD, and Colin W. Howden, MD
-
Guest Editor
Research Needs in Myeloma
Gregory R. Mundy, MD
-
Pharmacology and Therapeutic Use of Trastuzumab in Breast Cancer
By Imad Treish, PharmD, Rowena Schwartz, PharmD, BCOP, and Celeste Lindley, PharmD, BCPS, FASHP, FCCP
-
High-Dose Therapy in Patients with Multiple Myeloma
By Bhawna Sirohi, MBBS, DCH and Ray Powles, MD, MRCP, MRCPath
-
Diagnosis and Treatment of Depression in the Cancer Patient
Tracy L. Skaer, PharmD, Linda M. Robison, MSPH, David A. Sclar, PhD
